OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
42
Results
Show all
Save search
Copy query
Show results for
Unknown
(42)
Publication Date
Release Date
2022
(9)
2021
(9)
2025
(5)
2024
(3)
2023
(3)
2020
(3)
2015
(3)
2026
(1)
2019
(1)
2018
(1)
2017
(1)
2016
(1)
2014
(1)
2010
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
The genome of a songbird.
Not available
S-EPMC3187626
|
biostudies-literature
Cite
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Not available
S-EPMC7781100
|
biostudies-literature
Cite
BioTIME: A database of biodiversity time series for the Anthropocene.
Not available
S-EPMC6099392
|
biostudies-literature
Cite
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
Not available
S-EPMC8636568
|
biostudies-literature
Cite
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Not available
S-EPMC7217863
|
biostudies-literature
Cite
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
Not available
S-EPMC7217941
|
biostudies-literature
Cite
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Not available
S-EPMC10527239
|
biostudies-literature
Cite
VarSight: prioritizing clinically reported variants with binary classification algorithms.
Not available
S-EPMC6792253
|
biostudies-literature
Cite
Recombination Suppression Drives Expansion of the Drosophila Dot Chromosome.
Not available
S-EPMC12728734
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets